Search Results 361-370 of 13315 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  2. Medical Research & Education - Mayo Clinic News Network

    August 30, 2021. Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured. Featured News. Monoclonal ...

  3. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

  4. Trastuzumab-pkrb (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-pkrb is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  5. Medical Research & Education - Mayo Clinic News Network

    Research · Research · Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured · Science Saturday: Opioids ...

  6. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, interfere with the ability of cancer cells to grow and spread. It is not yet known whether fludarabine phosphate ...

  7. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  8. Trastuzumab-qyyp (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-qyyp is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  9. Blistering Clinical Trials - Mayo Clinic Research

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...

  10. Radiation Therapy With Or Without Cetuximab In Treating Patients Who Have Undergone Surgery For Locally Advanced Head And Neck Cancer - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...